{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T11:36:36Z","timestamp":1785497796604,"version":"3.56.0"},"reference-count":30,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Introduction: Suppression of Tumorigenicity 2 (ST2), a member of the interleukin-1 (IL-1) superfamily, is recognized as an important biomarker in inflammatory responses and cardiovascular diseases. Elevated serum levels of sST2 have prognostic value, particularly in cases of cardiac stress such as heart failure and acute pulmonary embolism (APE). We aimed to assess ST2 levels as a potential biomarker for right heart dysfunction in APE patients, particularly in the context of its limited predictive value for mortality and risk stratification. Methods: Patients diagnosed with APE confirmed via computed tomography pulmonary angiography (CTPA) were enrolled in this study. To ensure the specificity of sST2 elevation to APE, patients with other conditions known to cause elevated sST2 levels were excluded. Results: After pre-clinical evaluation, 66 patients diagnosed with APE who met the study criteria, and 62 healthy subjects in the control group, were included in this study. sST2 levels were positively correlated with APE. Conclusions: In patients diagnosed with APE, sST2 levels had high sensitivity. sST2 levels are elevated in APE and are associated with right ventricular dysfunction, but do not independently predict mortality or risk stratification based on Pulmonary Embolism Severity Index (PESI) scores.<\/jats:p>","DOI":"10.3390\/jcm13237211","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T10:05:56Z","timestamp":1732701956000},"page":"7211","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Soluble ST2 as a Biomarker for Predicting Right Ventricular Dysfunction in Acute Pulmonary Embolism"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5103-0141","authenticated-orcid":false,"given":"Muhammet","family":"Uyanik","sequence":"first","affiliation":[{"name":"Department of Cardiology, Carsamba State Hospital, 55500 Samsun, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5749-7124","authenticated-orcid":false,"given":"Ahmet","family":"Cinar","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Merzifon State Hospital, 05300 Amasya, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer","family":"Gedikli","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Faculty of Medicine, Ondokuz Mayis University, 55270 Samsun, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4386-8259","authenticated-orcid":false,"given":"Tibel","family":"Tuna","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Diseases, Faculty of Medicine, Ondokuz Mayis University, 55270 Samsun, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6471-6495","authenticated-orcid":false,"given":"Bahattin","family":"Avci","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Medicine, Ondokuz Mayis University, 55270 Samsun, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1055\/s-0034-1390325","article-title":"Thrombosis: A major contributor to global disease burden","volume":"40","author":"Raskob","year":"2014","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.amjcard.2004.01.058","article-title":"Estimated case fatality rate of pulmonary embolism, 1979 to 1998","volume":"93","author":"Stein","year":"2004","journal-title":"Am. J. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/eurheartj\/ehz405","article-title":"2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)","volume":"41","author":"Konstantinides","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cca.2020.04.011","article-title":"Soluble ST2: A complex and diverse role in several diseases","volume":"507","author":"Homsak","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1046\/j.1432-1327.1999.00615.x","article-title":"Different promoter usage and multiple transcription initiation sites of the interleukin-1 receptor-related human ST2 gene in UT-7 and TM12 cells","volume":"264","author":"Iwahana","year":"1999","journal-title":"Eur. J. Biochem."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Jirak, P., Mirna, M., Wernly, B., Paar, V., Hoppe, U.C., and Lichtenauer, M. (2020). Assessment of Cardiac Remodeling\u2014A Chance for Novel Cardiac Biomarkers?. J. Clin. Med., 9.","DOI":"10.3390\/jcm9072087"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/cvr\/cvq104","article-title":"Primary sources and immunological prerequisites for sST2 secretion in humans","volume":"87","author":"Mildner","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nri2692","article-title":"Disease-associated functions of IL-33: The new kid in the IL-1 family","volume":"10","author":"Liew","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"44B","DOI":"10.1016\/j.amjcard.2015.01.040","article-title":"ST2 in pulmonary disease","volume":"115","author":"Bajwa","year":"2015","journal-title":"Am. J. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Kotsiou, O.S., Gourgoulianis, K.I., and Zarogiannis, S.G. (2018). IL-33\/ST2 axis in organ fibrosis. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.02432"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1016\/j.ihj.2018.03.001","article-title":"ST2: Current status","volume":"70","author":"Dattagupta","year":"2018","journal-title":"Indian Heart J."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Somuncu, M.U., Kalayci, B., Avci, A., Akgun, T., Karakurt, H., Demir, A.R., Avci, Y., and Can, M. (2020). Predicting long-term cardiovascular outcomes of patients with acute myocardial infarction using soluble ST2. Horm. Mol. Biol. Clin. Investig., 41.","DOI":"10.1515\/hmbci-2019-0062"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"5362","DOI":"10.21037\/jtd.2019.11.66","article-title":"Relationship of soluble ST2 to pulmonary hypertension severity in patients undergoing cardiac resynchronization therapy","volume":"11","author":"Beaudoin","year":"2019","journal-title":"J. Thorac. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/bjh.15206","article-title":"Identification of novel diagnostic biomarkers for deep venous thrombosis","volume":"181","author":"Memon","year":"2018","journal-title":"Br. J. Haematol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s12185-022-03437-2","article-title":"Plasma biomarkers associated with survival and thrombosis in hospitalized COVID-19 patients","volume":"116","author":"Miltiades","year":"2022","journal-title":"Int. J. Hematol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1161\/CIRCULATIONAHA.117.030469","article-title":"Magnitude of Soluble ST2 as a Novel Biomarker for Acute Aortic Dissection","volume":"137","author":"Wang","year":"2018","journal-title":"Circulation"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1515\/cclm-2017-0762","article-title":"Increased serum concentrations of soluble ST2 are associated with pulmonary complications and mortality in polytraumatized patients","volume":"56","author":"Haider","year":"2018","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1161\/01.CIR.0000127958.21003.5A","article-title":"Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction","volume":"109","author":"Shimpo","year":"2004","journal-title":"Circulation"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1373\/clinchem.2011.173369","article-title":"Role of ST2 in Non\u2013ST-Elevation Acute Coronary Syndrome in the MERLIN-TIMI 36 Trial","volume":"58","author":"Kohli","year":"2012","journal-title":"Clin. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jchf.2013.10.005","article-title":"Head-to-head comparison of serial soluble ST2, growth differentiation factor-15, and highly-sensitive troponin T measurements in patients with chronic heart failure","volume":"2","author":"Gaggin","year":"2014","journal-title":"JACC. Heart Fail."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cca.2018.07.036","article-title":"Time-course of circulating cardiac and inflammatory biomarkers after Ventricular Assist Device implantation: Comparison between paediatric and adult patients","volume":"486","author":"Ragusa","year":"2018","journal-title":"Clin. Chim. Acta."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejim.2017.05.027","article-title":"A comparative analysis of novel cardiovascular biomarkers in patients with chronic heart failure","volume":"44","author":"Lichtenauer","year":"2017","journal-title":"Eur. J. Intern. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1017\/S1047951123000331","article-title":"Paediatric heart failure\u2014Understanding the pathophysiology and the current role of cardiac biomarkers in clinical practice","volume":"33","author":"Mcginn","year":"2023","journal-title":"Cardiol. Young"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ahj.2010.06.033","article-title":"Association of ST2 levels with cardiac structure and function and mortality in outpatients","volume":"160","author":"Daniels","year":"2010","journal-title":"Am. Heart J."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Petramala, L., Concistr\u00e8, A., Sarlo, F., Baroni, S., Suppa, M., Servello, A., Circosta, F., Galardo, G., Gandini, O., and Marino, L. (2023). Assessment of sST2 Behaviors to Evaluate Severity\/Clinical Impact of Acute Pulmonary Embolism. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24054591"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e20230040","DOI":"10.36660\/abc.20230040","article-title":"Association of soluble ST2 Level with 6-month Mortality and\/or Recurrent Cardiovascular-Related Hospitalization in Pulmonary Embolism","volume":"121","author":"Gunes","year":"2024","journal-title":"Arq. Bras. Cardiol."},{"key":"ref_28","first-page":"e42449","article-title":"Relationship Between Soluble ST2 Level and Chronic Thromboembolic Pulmonary Hypertension (CTEPH) in Acute Pulmonary Embolism (PE) Patients","volume":"15","author":"Gunes","year":"2023","journal-title":"Cureus"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"102756","DOI":"10.1016\/j.autrev.2021.102756","article-title":"Pathophysiologic role of Interleukin-33\/ST2 in Sj\u00f6gren\u2019s syndrome","volume":"20","author":"Soyfoo","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1080\/1354750X.2020.1821776","article-title":"Galectin-3, GDF-15, and sST2 for the assessment of disease severity and therapy response in patients suffering from inoperable chronic thromboembolic pulmonary hypertension","volume":"25","author":"Kriechbaum","year":"2020","journal-title":"Biomarkers"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/23\/7211\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:40:40Z","timestamp":1760114440000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/23\/7211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,27]]},"references-count":30,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["jcm13237211"],"URL":"https:\/\/doi.org\/10.3390\/jcm13237211","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,27]]}}}